Davene R. Wright, PhD
@wrightcensored.bsky.social
Associate Professor of Population Medicine @ Harvard & Auntie | decision sciences, #healthpolicy, child health, #medsky | storytelling, dresses, #F1 #TeamLH, libraries | opinions are my own
DaveneWright.com
DaveneWright.com
We need to see the dress!!
June 16, 2025 at 11:03 AM
We need to see the dress!!
This statement is not universally true. Plenty of economists, especially health economists, do human subjects research and are familiar with IRBs.
April 22, 2025 at 1:24 PM
This statement is not universally true. Plenty of economists, especially health economists, do human subjects research and are familiar with IRBs.
A recording of an April 10 Truveta webinar, "What's really happening with GLP-1s?" www.truveta.com/resources/we... (3/3)
What’s really happening with GLP-1s
See how real-time EHR data from over 120 million US patients, is accelerating insights on GLP-1 use and generating high-quality clinical evidence far faster than traditional trials.
www.truveta.com
April 16, 2025 at 9:22 PM
A recording of an April 10 Truveta webinar, "What's really happening with GLP-1s?" www.truveta.com/resources/we... (3/3)
Other events worth highlighting:
An NIDDK 1.5-day workshop from May 7-8: Leveraging Real-World Evidence to Assess Benefits and Risks of GLP-1-Based Therapies www.niddk.nih.gov/news/meeting... (2/3)
An NIDDK 1.5-day workshop from May 7-8: Leveraging Real-World Evidence to Assess Benefits and Risks of GLP-1-Based Therapies www.niddk.nih.gov/news/meeting... (2/3)
Leveraging Real-World Evidence to Assess Benefits and Risks of GLP-1-Based Therapies - 2025 - NIDDK
www.niddk.nih.gov
April 16, 2025 at 9:19 PM
Other events worth highlighting:
An NIDDK 1.5-day workshop from May 7-8: Leveraging Real-World Evidence to Assess Benefits and Risks of GLP-1-Based Therapies www.niddk.nih.gov/news/meeting... (2/3)
An NIDDK 1.5-day workshop from May 7-8: Leveraging Real-World Evidence to Assess Benefits and Risks of GLP-1-Based Therapies www.niddk.nih.gov/news/meeting... (2/3)